Caribou Biosciences, Inc.
CRBU
$0.735
$0.00190.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.85% | -246.77% | -27.70% | -47.03% | -27.85% |
| Total Depreciation and Amortization | 60.00% | -25.46% | 38.74% | 20.54% | 46.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.38% | 115.38% | -31.57% | 122.04% | 369.81% |
| Change in Net Operating Assets | -185.63% | 87.20% | -76.33% | 64.06% | 4,025.00% |
| Cash from Operations | -65.91% | -13.45% | -116.44% | -33.16% | 14.63% |
| Capital Expenditure | 77.25% | 85.84% | 12.22% | 28.71% | -29.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 156.29% | 142.67% | 72.15% | 7.35% | -1,097.51% |
| Cash from Investing | 150.61% | 138.73% | 91.61% | 10.88% | -2,790.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.82% | -99.25% | 660.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9,083.72% | -99.82% | -99.25% | 660.35% | -133.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.36% | -115.57% | -185.75% | 68.50% | -122.75% |